Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
View Top Employees from Cerevel Therapeutics| Website | https://www.cerevel.com |
| Ticker | CERE |
| Revenue | $63 million |
| Funding | $350 million |
| Employees | 345 (328 on RocketReach) |
| Founded | 2018 |
| Address | 222 Jacobs Street Suite 200, Suite 200, Cambridge, Massachusetts 02141, US |
| Phone | (844) 304-2048 |
| Technologies |
JavaScript,
HTML,
Twitter
+64 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Pharmaceutical, Health Care, Therapeutics |
| Keywords | Central Nervous System, Neurodegenerative Diseases, Psychiatric Treatments |
| Competitors | Acadia Pharmaceuticals Inc., Denali Therapeutics, Intra-Cellular Therapies, Sage Therapeutics, Vanda Pharmaceuticals |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies |
Looking for a particular Cerevel Therapeutics employee's phone or email?
Cerevel Therapeutics Questions
The Cerevel Therapeutics annual revenue was $63 million in 2024.
Douglas Barta is the CIO of Cerevel Therapeutics.
328 people are employed at Cerevel Therapeutics.
Cerevel Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for Cerevel Therapeutics are [325, 541, 32541, 3254, 54, 32].
The SIC codes for Cerevel Therapeutics are [87, 873].
Top Cerevel Therapeutics Employees
-
5+5+
-
55+
-
45
-
45+
-
13
-
25+
-
ViewErica Schwartz Koenig
Vice President Global Clinical Development at Cerevel Therapeutics
Cambridge, MA, US22
Related Companies
